GT200500365A - BIPEPTIDE NITRILS - Google Patents

BIPEPTIDE NITRILS

Info

Publication number
GT200500365A
GT200500365A GT200500365A GT200500365A GT200500365A GT 200500365 A GT200500365 A GT 200500365A GT 200500365 A GT200500365 A GT 200500365A GT 200500365 A GT200500365 A GT 200500365A GT 200500365 A GT200500365 A GT 200500365A
Authority
GT
Guatemala
Prior art keywords
bipeptide
nitrils
preparation
novedous
cyclhexyl
Prior art date
Application number
GT200500365A
Other languages
Spanish (es)
Inventor
Sabine Pfeffer
Frederic Nobs
Piotr H Karpinski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500365A publication Critical patent/GT200500365A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION ESTA ENFOCADO A LAS SALES NOVEDOSAS Y LAS MODIFICACIONES DE N[(1CIANOMETILOCARBAMOILO)CICLOHEXILO]4(4PROPILOPIPERAZINA1ILO)BENZAMIDA, SU USO EN MEDICINA, PROCESO PARA SU PREPARACION Y SU USO EN LA MANUFACTURA DE PREPARACIONES FARMACEUTICAS.THE PRESENT INVENTION IS FOCUSED ON NOVEDOUS SALTS AND MODIFICATIONS OF N [(1CIANOMETILOCARBAMOIL) CYCLHEXYL] 4 (4PROPILOPIPERAZINA1ILO) BENZAMIDA, ITS USE IN MEDICINE, PROCESS FOR PREPARATION AND USE IN PREPARATION OF MANUFACTURE.

GT200500365A 2004-12-14 2005-12-13 BIPEPTIDE NITRILS GT200500365A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427380.1A GB0427380D0 (en) 2004-12-14 2004-12-14 Organic compounds

Publications (1)

Publication Number Publication Date
GT200500365A true GT200500365A (en) 2006-07-17

Family

ID=34090027

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500365A GT200500365A (en) 2004-12-14 2005-12-13 BIPEPTIDE NITRILS

Country Status (6)

Country Link
AR (1) AR052161A1 (en)
GB (1) GB0427380D0 (en)
GT (1) GT200500365A (en)
PE (1) PE20060742A1 (en)
TW (1) TW200635910A (en)
WO (1) WO2006063762A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010519320A (en) * 2007-02-28 2010-06-03 サノフィ−アベンティス Imaging probe
EP2262783A2 (en) * 2008-02-21 2010-12-22 Sanofi-Aventis Covalently binding imaging probes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU751669B2 (en) * 1997-11-05 2002-08-22 Novartis Ag Dipeptide nitriles
GB0003111D0 (en) * 2000-02-10 2000-03-29 Novartis Ag Organic compounds
CA2532948A1 (en) * 2003-07-21 2005-02-17 Novartis Ag Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
AU2004290874A1 (en) * 2003-11-19 2005-06-02 Novartis Ag Use of cathepsin K inhibitors in severe bone loss diseases

Also Published As

Publication number Publication date
PE20060742A1 (en) 2006-09-08
TW200635910A (en) 2006-10-16
AR052161A1 (en) 2007-03-07
GB0427380D0 (en) 2005-01-19
WO2006063762A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
HN2003000054A (en) PHARMACEUTICAL DOSAGE FORMS OF CONTROLLED RELEASE OF AN INHIBITOR OF THE PROTEIN OF TRANSFER OF ESTER OF CHOLESTERILE (CETPI), TO PROCEDURES OF USE AND PROCEDURES OF PREPARATION OF THE SAME.
ECSP045491A (en) NEW VENLAFAXINA O-DESMETIL FORMAMATE SALT
ATE308341T1 (en) PHARMACEUTICAL FORMULATIONS
SE0100901D0 (en) New composition
ECSP066718A (en) DERIVATIVES OF PIRAZOLO [1,5-A] PIRIMIDIN-7-IL-AMINA FOR USE IN THE TREATMENT OF DEPENDENT DISEASES OF PROTEIN KINASE
UY27222A1 (en) PIRAZOLOPIRIMIDINAS AS THERAPEUTIC AGENTS
CR7042A (en) INDANIL ACILATED AMINAS AND ITS USE AS PHARMACOS
BRPI0513819A (en) hsp90 inhibitors
RS50876B (en) Use of flibanserin in the treatment of sexual disorders
AR052238A1 (en) FORMULATION OF STABLE TABLETS
AR025428A1 (en) FORMS OF DELAYED TRAMADOL ADMINISTRATION THROUGH A COATING CONTAINING THE ACTIVE TRAMADOL SUBSTANCE IN THE FORM OF A TRAMADOL SACARINATE EVENTUALLY ASSOCIATED OTHER EXCIPIENTS
RS51213B (en) Pharmacetical vaginal gel comprising tenofovir
CY1110721T1 (en) Use GLP-2 in combination with other therapeutic agents in bone diseases
PA8583601A1 (en) PIRROLIDONE DERIVATIVES AS MAOB INHIBITORS
ITMI20041810A1 (en) "SANITARY ITEM, EVEN FOR SPORTS USE, AND RELATED PRODUCTION METHOD"
UY26297A1 (en) VACCINE
ATE477710T1 (en) IMPROVED ORCHID CULTIVATION PROCESS
CR9639A (en) TISU PRODUCT FOR BATHROOM WRAPPED FOR CHILDREN
CY1106155T1 (en) USE OF 3-BENZOPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF AMPHIBLISTROID DISORDERS
UY29741A1 (en) SALTS OF 1,5- DIARIL PIRAZOL-3-CARBOXAMIDS, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, APPLICATIONS AND METHODS OF USE.
GT200500365A (en) BIPEPTIDE NITRILS
ATE411279T1 (en) ARYLSULFONAMIDOBENZYL COMPOUNDS
BRPI0507157A (en) use of factor viia or equivalent factor viia, parts kit for treating trauma, and methods for treating trauma and for preventing, treating trauma
UY28762A1 (en) NEW COMPOUNDS
BR0308795A (en) Sulfamic Acid Amides